Latest updates for Eras

Fresh curated links around ERAS are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Biotech Fund Sells $44.5 Million Erasca Stake After Massive 700% Rally
  • Pomerantz LLP Informs Investors of Securities Class Action Against Erasca, Inc. – ERAS

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

fool.com /1 month ago

Biotech Fund Sells $44.5 Million Erasca Stake After Massive 700% Rally

This clinical-stage biotech develops targeted therapies for RAS/MAPK pathway cancers, advancing a pipeline of novel oncology candidates.

Read source
newswire.com /1 week ago

Pomerantz LLP Informs Investors of Securities Class Action Against Erasca, Inc. – ERAS

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Start creating posts

Sources covering Eras

fool.com

Recent coverage from public sources
Public source

newswire.com

Recent coverage from public sources
Public source

Related searches

6dee1dde-766d-41d5-a5da-00952f0fd817 ERAS Health Care coveragefilings

Recent searches

Artificial Intelligence Machine Learning Data Science Data Engineering Business Intelligence Web Development Software Development Software Testing Programming JavaScript DevOps Cyber Security Product Management Project Management Design UX UX Research Graphic Design Video Production Video Editing